Enhanced production of transforming growth factor-beta (TGF-β) during autologous mixed lymphocyte reaction of systemic sclerosis patients

9Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Systemic sclerosis (SSc) is characterized by systemic fibrosis and microvascular lesions. As TGF-β is suggested to be related to skin fibrosis, we examined the production of TGF-β from peripheral mononuclear cells (MNC) of SSc patients. Since anti-TGF-β neutralizing antibody improved the defective proliferative response in autologous mixed lymphocyte reaction (AMLR) of SSc patients, TGF-β was thought to participate in the decreased AMLR of SSc patients. Greater amounts of TGF-β in the active as well as in the latent forms were produced during AMLR of SSc patients than that of normal subjects. It was suggested that TGF-β excessively produced from the MNC of SSc patients might play a major role in the fibrosis of the patients during AMLR-like in vivo responses.

Cite

CITATION STYLE

APA

Ota, H., Kumagai, S., Morinobu, A., Yanagida, H., & Nakao, K. (1995). Enhanced production of transforming growth factor-beta (TGF-β) during autologous mixed lymphocyte reaction of systemic sclerosis patients. Clinical and Experimental Immunology, 100(1), 99–103. https://doi.org/10.1111/j.1365-2249.1995.tb03609.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free